If this EO gets brand pharma to sell to us ( they won't know out of fear of PBMs), at anywhere near what the PBMs get ( higher , but fair ) , and we will offer cash pricing that will get close to what he wants. It's analogue to what happened with Trumps hospital pricing transparency The biggest insurance comps, (they own the PBMs), ig negotiate with hospitals and their prices are almost always higher than the cash price. So anyone with a credit card can get better pricing than what the big companies negotiate. We can make the same thing happen with brand meds. Just like we did with generic meds